Larimar Therapeutics Inc (LRMR)
6.46
+0.06
(+0.94%)
USD |
NASDAQ |
Apr 23, 16:00
6.48
+0.02
(+0.31%)
After-Hours: 20:00
Larimar Therapeutics Total Assets (Quarterly): 95.94M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 95.94M |
| September 30, 2023 | 103.95M |
| June 30, 2023 | 111.72M |
| March 31, 2023 | 118.91M |
| December 31, 2022 | 126.40M |
| September 30, 2022 | 133.02M |
| June 30, 2022 | 62.85M |
| March 31, 2022 | 71.22M |
| Date | Value |
|---|---|
| December 31, 2021 | 78.67M |
| September 30, 2021 | 87.94M |
| June 30, 2021 | 80.93M |
| March 31, 2021 | 93.02M |
| December 31, 2020 | 104.69M |
| September 30, 2020 | 113.96M |
| June 30, 2020 | 125.46M |
| December 31, 2019 | 5.201M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.201M
Minimum
Dec 2019
133.02M
Maximum
Sep 2022
94.62M
Average
99.94M
Median
Total Assets (Quarterly) Benchmarks
| Cogent Biosciences Inc | 313.44M |
| ACADIA Pharmaceuticals Inc | 748.96M |
| PTC Therapeutics Inc | 1.896B |
| Renovaro Inc | 58.02M |
| G1 Therapeutics Inc | 121.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.22M |
| Shareholders Equity (Quarterly) | 81.72M |